Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone to Prevent Fibrosis in ARDS (PIONEER)
NCT05075161Phase 3Recruiting
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Jun 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pirfenidone in acute respiratory distress syndrome (ARDS), sponsored by Vita-Salute San Raffaele University. Started Jun 2022; status: recruiting.
02
Drugs
pirfenidone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05075161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05075161.